Glucagon-like peptide-1 (GLP-1) receptors expressed on nerve terminals in the portal vein mediate the effects of endogenous GLP-1 on glucose tolerance in rats
CrossRef Hormonal GutBrain Signaling for the Treatment of Obesity Eun Roh, Kyung Mook Choi International Journal of Molecular Sciences.2023
Knockout or inhibition of USP30 protects dopaminergic neurons in a Parkinsons disease mouse model
This supplement provides L-Carnitine to support energy metabolism, exercise performance, and overall cardiovascular health
Hullon D, Subeh GK, Volkova Y, Janiec K, Trach A, Mnevets R
The primary benefits of GLP-1 therapy include: Sustained Weight Management: By slowing digestion and increasing the duration of fullness, these medications help patients lose between 10% and 22% of their body weight, depending on the specific drug used